Recent Advances in Moyamoya Disease: Pathophysiology and Treatment
- 6 December 2013
- journal article
- review article
- Published by Springer Nature in Current Neurology and Neuroscience Reports
- Vol. 14 (1) , 1-9
Abstract
Moyamoya disease is a progressive intracranial arteriopathy characterized by bilateral stenosis of the distal portion of the internal carotid artery and the proximal anterior and middle cerebral arteries, resulting in transient ischemic attacks or strokes. The pathogenesis of moyamoya disease remains unresolved, but recent advances have suggested exciting new insights into a genetic contribution as well as into other pathophysiological mechanisms. Treatment that may halt progression of the disease or even reverse the intracranial arteriopathy is yet to be found. There are strong indications that neurosurgical intervention, through direct, indirect, or combined revascularization surgery, can reduce the risk of ischemic stroke and possibly also cognitive dysfunction by improving cerebral perfusion, although randomized clinical trials have not been performed. Many questions regarding the indication for and timing of surgery remain unanswered. In this review, we discuss recent developments in the pathogenesis and treatment of moyamoya disease.Keywords
This publication has 86 references indexed in Scilit:
- Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patientsBiochemical and Biophysical Research Communications, 2013
- Intracranial atherosclerotic disease associated with moyamoya collateral formation: histopathological findingsJournal of Neurosurgery, 2013
- Outer-diameter narrowing of the internal carotid and middle cerebral arteries in moyamoya disease detected on 3D constructive interference in steady-state MR image: is arterial constrictive remodeling a major pathogenesis?Acta Neurochirurgica, 2012
- Moyamoya disease: functional and neurocognitive outcomes in the pediatric and adult populationsNeurosurgical Focus, 2011
- Increased Thyroid Function and Elevated Thyroid Autoantibodies in Pediatric Patients With Moyamoya DiseaseStroke, 2011
- Clinical outcome after 450 revascularization procedures for moyamoya diseaseJournal of Neurosurgery, 2009
- Management of Stroke in Infants and ChildrenStroke, 2008
- Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprintingJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Study Design for a Prospective Randomized Trial of Extracranial-Intracranial Bypass Surgery for Adults With Moyamoya Disease and Hemorrhagic Onset-The Japan Adult Moyamoya Trial Group-Neurologia medico-chirurgica, 2004
- Cerebral dissecting aneurysms in patients with moyamoya diseaseJournal of Neurosurgery, 1983